Product Portfolio
Browse our complete classified catalog of finished pellets, custom release formulations, combinations, and active pipeline compounds engineered to global pharmacopeial standards.
Browse our complete classified catalog of finished pellets, custom release formulations, combinations, and active pipeline compounds engineered to global pharmacopeial standards.
| Therapeutic Segment | Active Ingredient Name | Release | Available Strength/Percentages |
|---|
| System Classification | Combination Formula Product Name | Dosage Formulation / Milligram Weights |
|---|---|---|
| Anti-Ulcer Combination | Omeprazole EC + Domperidone IR | 20 mg + 10 mg |
| Omeprazole EC + Domperidone SR | 20 mg + 30 mg | |
| Rabeprazole EC + Domperidone SR | 20 mg + 30 mg | |
| Rabeprazole EC + Domperidone IR+SR | 20 mg + 30 mg | |
| Rabeprazole EC + Levosulpiride SR | 20 mg + 75 mg | |
| Rabeprazole EC + Itopride HCl SR | 20 mg + 150 mg | |
| Rabeprazole EC + Aceclofenac SR | 20 mg + 200 mg | |
| Rabeprazole EC + Diclofenac SR | 20 mg + 100 mg | |
| Pantoprazole EC + Domperidone SR | 40 mg + 30 mg | |
| Pantoprazole EC + Domperidone IR+SR | 40 mg + 30 mg | |
| Pantoprazole EC + Levosulpiride SR | 40 mg + 75 mg | |
| Pantoprazole EC + Cinitapride SR | 40 mg + 3 mg | |
| Pantoprazole EC + Itopride HCl SR | 40 mg + 150 mg | |
| Pantoprazole EC + Domperidone IR | 20 mg + 10 mg | |
| Esomeprazole EC + Domperidone SR | 20 mg + 30 mg | |
| Esomeprazole EC + Domperidone SR | 40 mg + 30 mg | |
| Esomeprazole EC + Levosulpiride SR | 40 mg + 75 mg | |
| Esomeprazole EC + Itopride HCl SR | 40 mg + 150 mg | |
| BPH Combination | Tamsulosin HCl SR + Dutasteride | 0.4 mg + 0.5 mg |
| Vitamin / Mineral Active Form | Standard Assay Percentages |
|---|---|
| Carbonyl Iron Pellets | 35%, 50%, 70% |
| Folic Acid Pellets | 1.0%, 3.0%, 5.0% |
| Zinc Sulphate Monohydrate Pellets | 35%, 50%, 70% |
| Selenium Pellets | 0.01% |
| Vitamin B12 Pellets | 0.2% |
| Ascorbic Acid Pellets (Vitamin C) | 0.7% |
| Pyridoxine Hydrochloride (B6) Pellets | 5.0%, 15% |
Products are supplied in strict compliance with IP/BP/USP standards. Patent Disclaimer: Products protected by valid patents are not offered or supplied to territories where such patents are in force. Final patent non-infringement liability rests exclusively with the purchasing entity.